@article{aa63669c6b2f4aaf8bfafa6c37f4c7e5,
title = "A stepwise approach to implementing pharmacogenetic testing in the primary care setting",
abstract = "Pharmacogenetic testing can help identify primary care patients at increased risk for medication toxicity, poor response or treatment failure and inform drug therapy. While testing availability is increasing, providers are unprepared to routinely use pharmacogenetic testing for clinical decision-making. Practice-based resources are needed to overcome implementation barriers for pharmacogenetic testing in primary care.The NHGRI's IGNITE I Network (Implementing GeNomics In pracTicE; www.ignite-genomics.org) explored practice models, challenges and implementation barriers for clinical pharmacogenomics. Based on these experiences, we present a stepwise approach pharmacogenetic testing in primary care: patient identification; pharmacogenetic test ordering; interpretation and application of test results, and patient education. We present clinical factors to consider, test-ordering processes and resources, and provide guidance to apply test results and counsel patients. Practice-based resources such as this stepwise approach to clinical decision-making are important resources to equip primary care providers to use pharmacogenetic testing.",
keywords = "clinic, implementation, pharmacogenetics, pharmacogenomics, precision medicine, primary care",
author = "Weitzel, {Kristin Wiisanen} and Duong, {Benjamin Q.} and Arwood, {Meghan J.} and Aniwaa Owusu-Obeng and Abul-Husn, {Noura S.} and Bernhardt, {Barbara A.} and Brian Decker and Denny, {Joshua C.} and Eric Dietrich and John Gums and Madden, {Ebony B.} and Pollin, {Toni I.} and Wu, {Rebekah Ryanne} and Haga, {Susanne B.} and Horowitz, {Carol R.}",
note = "Funding Information: This work was supported by National Institutes of Health grants (grant numbers U01 HG007269, U01 GM074492, U01 HL105198 [KW Weitzel]; 5U01HG7278, 3U01HG00871-02S1, U01HG006380 [A Owusu-Obeng]; U01HG007253 [JC Denny]; U01HG007775 [TI Pollin]; 1U01HG007282-01 [RR Wu]; and National Center for Advancing Translational Sciences grants UL1TR000064 and UL1TR001427 [KW Weitzel]). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. Funding Information: This work was supported by National Institutes of Health grants (grant numbers U01 HG007269, U01 GM074492, U01 HL105198 [KW Weitzel]; 5U01HG7278, 3U01HG00871-02S1, U01HG006380 [A Owusu-Obeng]; U01HG007253 [JC Denny]; U01HG007775 [TI Pollin]; 1U01HG007282-01 [RR Wu]; and National Center for Advancing Translational Sciences grants UL1TR000064 and UL1TR001427 [KW Weitzel]). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript. Publisher Copyright: {\textcopyright} 2019 {\textcopyright} 2019 Future Medicine Ltd.",
year = "2019",
doi = "10.2217/pgs-2019-0053",
language = "English",
volume = "20",
pages = "1103--1112",
journal = "Pharmacogenomics",
issn = "1462-2416",
publisher = "Future Medicine Ltd.",
number = "15",
}